Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Total Debt (2016 - 2022)

Fennec Pharmaceuticals (FENC) has disclosed Total Debt for 8 consecutive years, with $25.0 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Total Debt changed N/A year-over-year to $25.0 million, compared with a TTM value of $25.0 million through Sep 2022, changed N/A, and an annual FY2017 reading of $167.0 million, up 505960.61% over the prior year.
  • Total Debt was $25.0 million for Q3 2022 at Fennec Pharmaceuticals, up from $5.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $25.0 million in Q3 2022 and bottomed at $5.0 million in Q1 2022.